Publication Cover
Mycology
An International Journal on Fungal Biology
Volume 15, 2024 - Issue 1: Pathogenic Fungi and Health
609
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Isolation of triazole-resistant Aspergillus fumigatus harbouring cyp51A mutations from five patients with invasive pulmonary aspergillosis in Yunnan, China

, , , , , & show all
Pages 85-90 | Received 29 Sep 2023, Accepted 20 Dec 2023, Published online: 03 Jan 2024

References

  • Albarrag AM, Anderson MJ, Howard SJ, Robson GD, Warn PA, Sanglard D, Denning DW. 2011. Interrogation of related clinical pan-azole-resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A, and integration and activation of transposon Atf1 in the cyp51A promoter. Antimicrob Agents Chemother. 55(11):5113–5121. doi: 10.1128/AAC.00517-11.
  • Arastehfar A, Carvalho A, Houbraken J, Lombardi L, Garcia-Rubio R, Jenks JD, Rivero-Menendez O, Aljohani R, Jacobsen ID, Berman J, et al. 2021. Aspergillus fumigatus and aspergillosis: From basics to clinics. Stud Mycol. 100:100115. doi: 10.1016/J.SIMYCO.2021.100115.
  • Camps SMT, Dutilh BE, Arendrup MC, Rijs AJMM, Snelders E, Huynen MA, Verweij PE, Melchers WJG, Fisher MC. 2012. Discovery of a HapE mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossing. PLoS One. 7(11):e50034. doi: 10.1371/JOURNAL.PONE.0050034.
  • Chen J, Li H, Li R, Bu D, Wan Z. 2005. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma. J Antimicrob Chemother. 55(1):31–37. doi: 10.1093/JAC/DKH507.
  • Chen Y, Dong F, Zhao J, Fan H, Qin C, Li R, Verweij PE, Zheng Y, Han L. 2020. High azole resistance in Aspergillus fumigatus isolates from strawberry fields, China, 2018. Emerg Infect Dis. 26(1):81–89. doi: 10.3201/EID2601.190885.
  • Chen Y, Lu Z, Zhao J, Zou Z, Gong Y, Qu F, Bao Z, Qiu G, Song M, Zhang Q, et al. 2016. Epidemiology and molecular characterizations of azole resistance in clinical and environmental Aspergillus fumigatus isolates from China. Antimicrob Agents Chemother. 60(10):5878–5884. doi: 10.1128/AAC.01005-16.
  • Clinical and Laboratory Standards Institute. 2017. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. In: Alexander B, editor. CLSI document M38-A3. 2nd ed. Wayne, PA: Clinical and Laboratory Standards Institute; pp. 1–13.
  • Clinical and Laboratory Standards Institute. 2020. Epidemiological cutoff values for antifungal susceptibility testing. In: Tertel M, editor. 3rd ed. CLSI supplement M59. Wayne, PA: Clinical and Laboratory Standards Institute; pp. 1–12.
  • Coleman JJ, Mylonakis E. 2009. Efflux in fungi: La pièce de résistance. PLoS Pathog. 5(6):e1000486. doi: 10.1371/JOURNAL.PPAT.1000486.
  • Fanning S, Mitchell AP, Heitman J. 2012. Fungal biofilms. PLoS Pathog. 8(4):e1002585. doi: 10.1371/JOURNAL.PPAT.1002585.
  • Fisher MC, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell EM, Bowyer P, Bromley M, Brüggemann R, Garber G, Cornely OA, et al. 2022. Tackling the emerging threat of antifungal resistance to human health. Nat Rev Microbiol. 20(9):557–571. doi: 10.1038/S41579-022-00720-1.
  • Garcia-Rubio R, Cuenca-Estrella M, Mellado E. 2017. Triazole resistance in Aspergillus species: An emerging problem. Drugs. 77(6):599–613. doi: 10.1007/S40265-017-0714-4.
  • Garcia-Vidal C, Peghin M, Cervera C, Gudiol C, Ruiz-Camps I, Moreno A, Royo-Cebrecos C, Roselló E, La Bellacasa JP D, Ayats J, et al. 2015. Causes of death in a contemporary cohort of patients with invasive aspergillosis. PLoS One. 10(3):e0120370. doi: 10.1371/JOURNAL.PONE.0120370.
  • Handelman M, Meir Z, Scott J, Shadkchan Y, Liu W, Ben-Ami R, Amich J, Osherov N. 2021. Point mutation or overexpression of Aspergillus fumigatus cyp51B, encoding lanosterol 14α-sterol demethylase, leads to triazole resistance. Antimicrob Agents Chemother. 65(10):0125221. doi: 10.1128/AAC.01252-21.
  • Krishnan-Natesan S, Chandrasekar PH, Alangaden GJ, Manavathu EK. 2008. Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases a (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus. Int J Antimicrob Agents. 32(6):519–524. doi: 10.1016/J.IJANTIMICAG.2008.06.018.
  • Krishnan Natesan S, Wu W, Cutright JL, Chandrasekar PH. 2012. In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus. Diagn Microbiol Infect Dis. 74(3):272–277. doi: 10.1016/j.diagmicrobio.2012.06.030.
  • Kwon-Chung KJ, Sugui JA, Heitman J. 2013. Aspergillus fumigatus—What makes the species a ubiquitous human fungal pathogen? PLoS Pathog. 9(12):1–4. doi: 10.1371/JOURNAL.PPAT.1003743.
  • Latgé JP. 1999. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev. 12(2):310–350. doi: 10.1128/CMR.12.2.310.
  • Liang T, Yang X, Li R, Yang E, Wang Q, Osherov N, Chen W, Wan Z, Liu W. 2021. Emergence of W272C substitution in Hmg1 in a triazole-resistant isolate of Aspergillus fumigatus from a Chinese patient with chronic cavitary pulmonary aspergillosis. Antimicrob Agents Chemother. 65(7):0026321. doi: 10.1128/AAC.00263-21.
  • Losada L, Sugui JA, Eckhaus MA, Chang YC, Mounaud S, Figat A, Joardar V, Pakala SB, Pakala S, Venepally P, et al. 2015. Genetic analysis using an isogenic mating pair of Aspergillus fumigatus identifies azole resistance genes and lack of MAT locus’s role in virulence. PLoS Pathog. 11(4):e1004834. doi:10.1371/JOURNAL.PPAT.1004834.
  • Ren J, Jin X, Zhang Q, Zheng Y, Lin D, Yu Y. 2017. Fungicides induced triazole-resistance in Aspergillus fumigatus associated with mutations of TR46/Y121F/T289A and its appearance in agricultural fields. J Hazard Mater. 326:54–60. doi: 10.1016/J.JHAZMAT.2016.12.013.
  • Slaven JW, Anderson MJ, Sanglard D, Dixon GK, Bille J, Roberts IS, Denning DW. 2002. Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate. Fungal Genet Biol. 36(3):199–206. doi: 10.1016/S1087-1845(02)00016-6.
  • Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, et al. 2018. Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 24(Suppl 1):e1–e38. doi:10.1016/J.CMI.2018.01.002.
  • Verweij PE, Snelders E, Kema GH, Mellado E, Melchers WJ. 2009. Azole resistance in Aspergillus fumigatus: A side-effect of environmental fungicide use? Lancet Infect Dis. 9(12):789–795. doi: 10.1016/S1473-3099(09)70265-8.
  • Verweij PE, Zhang J, Debets AJM, Meis JF, van de Veerdonk FL, Schoustra SE, Zwaan BJ, Melchers WJG, van de Veerdonk FL. 2016. In-host adaptation and acquired triazole resistance in Aspergillus fumigatus: A dilemma for clinical management. Lancet Infect Dis. 16(11):e251–e260. doi: 10.1016/S1473-3099(16)30138-4.
  • WHO. 2022. WHO fungal priority pathogens list to guide research, development, and public health action. License: CC BY-NC-SA 3.0 IGO. Geneva: World Health Organization. https://iris.who.int/bitstream/handle/10665/363682/9789240060241-eng.pdf?sequence=1.
  • Zhou D, Korfanty GA, Mo M, Wang R, Li X, Li H, Li S, Wu JY, Zhang KQ, Zhang Y, et al. 2021. Extensive genetic diversity and widespread azole resistance in greenhouse populations of Aspergillus fumigatus in Yunnan, China. China mSphere. 6(1):e00066–21. doi: 10.1128/MSPHERE.00066-21.
  • Zhou D, Wang R, Li X, Peng B, Yang G, Zhang KQ, Zhang Y, Xu J. 2022. Genetic diversity and azole resistance among natural Aspergillus fumigatus populations in Yunnan, China. Microb Ecol. 83(4):869–885. doi: 10.1007/S00248-021-01804-W.